CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch ...

Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping dataset in neurodegenerative brain tissue using ...

In this webinar, we will briefly introduce Vizgen’s Vizgen® MERSCOPE® Platform for spatial transcriptomics. Following this introduction, we will showcase the capabilities of MERSCOPE in deciphering ...

In this presentation, Vizgen’s Instrument Product Manager will introduce you to their latest platform, the MERSCOPE® Ultra, for in situ spatial genomics powered by MERFISH technology. MERFISH ...

Cell atlasing efforts rest on a deceptively simple premise: To understand a tissue, you must find every cell in it, including the rare populations and transitional states whose biology is often the ...

The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...

A novel spatial transcriptomics atlas developed by Northwestern Medicine scientists may improve the understanding of niche cellular interactions in the gastrointestinal tract that promote the ...